R Arbogast
Overview
Explore the profile of R Arbogast including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
247
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Arbogast R
Chirurg
. 2010 Jun;
81(8):691-3.
PMID: 20552153
The present day and future requirement profiles for leading surgeons have become manifold and are defined as such. Many requirements are teachable and learnable, such as economy and management. It...
3.
Schimanski C, Mohler M, Zimmermann T, Gockel I, Lang H, Arbogast R, et al.
Dtsch Med Wochenschr
. 2010 May;
135(21):1078-82.
PMID: 20486059
Colorectal cancer is one of the three most frequent malignancies in humans. Survival is mainly determined by local recurrence, lymphatic and hematogenous dissemination. Primary liver resection for metastases is possible...
4.
Link K, Kornmann M, Bittner R, Kockerling F, Arbogast R, Gastinger I, et al.
Chirurg
. 2009 Sep;
81(3):222-30.
PMID: 19760377
The surgeon is the key "prognosis factor" for colorectal cancer. For this reason quality criteria were recently established (including minimum numbers) in order to treat patients who are entitled to...
5.
6.
Beger H, Arbogast R
Langenbecks Arch Surg
. 2006 Mar;
391(2):143-8.
PMID: 16570205
Background And Aims: In the future, new surgical techniques will only be introduced in clinical practice if evidence-based results--frequently the results of controlled clinical trials--are presented. Unlike any other medical...
7.
Hepatic disseminated tumor cells in colorectal cancer UICC stage 4 patients: prognostic implications
Schimanski C, Linnemann U, Galle P, Arbogast R, Berger M
Int J Oncol
. 2003 Jul;
23(3):791-6.
PMID: 12888919
Approximately 30-50% of all colorectal cancer patients with a resectable primary tumor will subsequently develop metastatic disease due to tumor cell dissemination. In the case of limited solid hepatic metastasis,...
8.
Schimanski C, Linnemann U, Arbogast R, Berger M
Oncol Rep
. 2000 Dec;
8(1):185-8.
PMID: 11115595
Liver metastasis, as well as local recurrence, are delineating factors of postoperative survival in patients suffering from colorectal cancer. We set up a PCR-RFLP assay to detect K-ras mutated cells...
9.
Arbogast R, Jue S
Pharmacotherapy
. 2000 Mar;
20(2):199-205.
PMID: 10678298
We reviewed records of outpatients to determine the therapeutic failure rate of cephalexin in treating uncomplicated cellulitis. Therapeutic failure was defined as an increase in antibiotic dosage, prescription renewal, or...
10.